mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.8 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.8 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |